{"id":14233,"date":"2018-08-30T14:35:24","date_gmt":"2018-08-30T12:35:24","guid":{"rendered":"https:\/\/news.embl.de\/?p=14233"},"modified":"2026-04-21T16:33:32","modified_gmt":"2026-04-21T14:33:32","slug":"phenomenal-metabolomics-analysis","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/","title":{"rendered":"PhenoMeNal: an online portal for metabolomics"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>The PhenoMeNal project has launched an updated portal\u00a0for large scale clinical metabolomics data analysis<\/li>\n\n\n\n<li>The project is part of the EU\u2019s Horizon2020 Programme and includes 14 partners<\/li>\n\n\n\n<li>Metabolomics could become an essential tool for precision medicine, to help with patient diagnosis and determining possible treatment options<\/li>\n<\/ul>\n\n\n\n<p>An international collaboration between <a href=\"http:\/\/www.ebi.ac.uk\" target=\"_blank\" rel=\"noopener noreferrer\">EMBL\u2019s European Bioinformatics Institute (EMBL-EBI)<\/a> and 13 other partners has made large-scale metabolomics analyses easier with the launch of PhenoMeNal. This online portal allows researchers and clinicians to analyse large metabolomics datasets. For example, researchers can search for patterns in a patient\u2019s data. They can then use the findings to improve the detection of disease and to help optimise treatment. This project has received funding from the European Union\u2019s Horizon 2020 research and innovation programme.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What is metabolomics?<\/h2>\n\n\n\n<p>Metabolomics has the potential to become an essential tool for precision medicine. Metabolomics studies small molecules commonly known as metabolites, which exist in all cells, biofluids, tissues and organs.<\/p>\n\n\n\n<p>Metabolites and their concentrations reflect the underlying biochemical activity and thereby the health of cells or tissues. When applied to urine, blood or spinal fluid samples, metabolomics analyses can reveal whether a patient has a specific disease.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Understand molecular drivers of health<\/h2>\n\n\n\n<p>\u201cAfter three years of community-driven development, PhenoMeNal is ready to serve its users,\u201d explains Namrata Kale, PhenoMeNal Project Manager at EMBL-EBI. \u201cThe online portal uses state-of-the-art methods to understand the molecular drivers of health, ageing and disease. Researchers require no programming experience to easily and securely analyse patient data. PhenoMeNal enables them to get a better picture of how individual patients differ at a molecular level \u2013 this is key for precision medicine.\u201d<\/p>\n\n\n\n<p>PhenoMeNal allows clinicians to perform complex metabolomics analyses in line with privacy and ethics regulations. The portal uses the <a href=\"https:\/\/www.elixir-europe.org\/services\/compute\/aai\" target=\"_blank\" rel=\"noopener noreferrer\">ELIXIR Authorisation and Authentication Infrastructure<\/a>, which makes it safe and secure.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Streamline metabolomics data analysis<\/h2>\n\n\n\n<p>\u201cPhenoMeNal has enabled us to streamline our metabolomics data analysis and resolve several computational challenges,\u201d says Kim Kultima, a researcher at Uppsala University. \u201cToday, we perform all of our targeted and untargeted metabolomics analyses in computational environments that have been developed within PhenoMeNal. Our latest work, integrating metabolomics data with other types of phenotypic data for improved diagnosis of multiple sclerosis patients, would not have been accomplished without the developments and efforts made within the PhenoMeNal consortium.\u201d<\/p>\n\n\n\n<p>\u201cWe would like to encourage researchers working with metabolomics data to explore the PhenoMeNal Gateway, test our robust tools and workflows and send us their feedback using the PhenoMeNal website,\u201d says Kale. \u201cWe hope clinical researchers everywhere will make use of this open access portal for metabolomics analysis.\u201d<\/p>\n\n\n\n<p>This post was originally published on <a href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/PhenoMeNal-metabolomics\" target=\"_blank\" rel=\"canonical nofollow noopener noreferrer\" data-href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/PhenoMeNal-metabolomics\">EMBL-EBI News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Complex metabolomics analyses in the cloud<\/p>\n","protected":false},"author":47,"featured_media":14234,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,17591],"tags":[28,297,189,36,212,219,1748],"embl_taxonomy":[],"class_list":["post-14233","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","category-science-technology","tag-bioinformatics","tag-biomedical","tag-computational-biology","tag-embl-ebi","tag-medicine","tag-metabolomics","tag-press-release"],"acf":{"article_intro":"<p>PhenoMeNal enables researchers to perform complex metabolomics analyses in the cloud<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"in_this_article":false,"youtube_url":"","mp4_url":"","video_caption":"","translations":false,"press_contact":"EMBL-EBI Generic","vfwp-news_embl_taxonomy":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"source_article":false,"article_translations":false,"languages":""},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PhenoMeNal: an online portal for metabolomics | EMBL<\/title>\n<meta name=\"description\" content=\"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PhenoMeNal: an online portal for metabolomics | EMBL\" \/>\n<meta property=\"og:description\" content=\"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-30T12:35:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T14:33:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2334\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oana Stroe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oana Stroe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\"},\"author\":{\"name\":\"Oana Stroe\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\"},\"headline\":\"PhenoMeNal: an online portal for metabolomics\",\"datePublished\":\"2018-08-30T12:35:24+00:00\",\"dateModified\":\"2026-04-21T14:33:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\"},\"wordCount\":446,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg\",\"keywords\":[\"bioinformatics\",\"biomedical\",\"computational biology\",\"embl-ebi\",\"medicine\",\"metabolomics\",\"press release\"],\"articleSection\":[\"Science\",\"Science &amp; Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\",\"url\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\",\"name\":\"PhenoMeNal: an online portal for metabolomics | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg\",\"datePublished\":\"2018-08-30T12:35:24+00:00\",\"dateModified\":\"2026-04-21T14:33:32+00:00\",\"description\":\"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg\",\"width\":2334,\"height\":1600,\"caption\":\"Metabolomics could become a useful tool for precision medicine. PHOTO: PhenoMeNal\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\",\"name\":\"Oana Stroe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"caption\":\"Oana Stroe\"},\"description\":\"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.\",\"url\":\"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PhenoMeNal: an online portal for metabolomics | EMBL","description":"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/","og_locale":"en_US","og_type":"article","og_title":"PhenoMeNal: an online portal for metabolomics | EMBL","og_description":"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.","og_url":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2018-08-30T12:35:24+00:00","article_modified_time":"2026-04-21T14:33:32+00:00","og_image":[{"width":2334,"height":1600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","type":"image\/jpeg"}],"author":"Oana Stroe","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Oana Stroe","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/"},"author":{"name":"Oana Stroe","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414"},"headline":"PhenoMeNal: an online portal for metabolomics","datePublished":"2018-08-30T12:35:24+00:00","dateModified":"2026-04-21T14:33:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/"},"wordCount":446,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","keywords":["bioinformatics","biomedical","computational biology","embl-ebi","medicine","metabolomics","press release"],"articleSection":["Science","Science &amp; Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/","url":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/","name":"PhenoMeNal: an online portal for metabolomics | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","datePublished":"2018-08-30T12:35:24+00:00","dateModified":"2026-04-21T14:33:32+00:00","description":"EMBL-EBI and partners have launched the PhenoMeNal portal, which allows researchers and clinicians to perform complex metabolomics analyses.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/science\/phenomenal-metabolomics-analysis\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","width":2334,"height":1600,"caption":"Metabolomics could become a useful tool for precision medicine. PHOTO: PhenoMeNal"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414","name":"Oana Stroe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","caption":"Oana Stroe"},"description":"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.","url":"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/08\/PhenoMeNal_EMBL-EBI_620x425.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=14233"}],"version-history":[{"count":13,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14233\/revisions"}],"predecessor-version":[{"id":79155,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14233\/revisions\/79155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/14234"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=14233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=14233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=14233"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=14233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}